Deep learning-based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET images
Creators
- 1. Department of Nuclear Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, No. 321, Zhongshan Road, 210008, Nanjing City, Jiangsu Province (China)
- 2. National Institute of Healthcare Data Science at Nanjing University, Nanjing (China)
- 3. Department of Nuclear Medicine, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing (China)
- 4. State Key Laboratory for Novel Software Technology, Nanjing University, Nanjing (China)
- 5. Medical School of Nanjing University, Nanjing (China)
Description
To demonstrate the effectiveness of automatic segmentation of diffuse large B-cell lymphoma (DLBCL) in 3D FDG-PET scans using a deep learning approach and validate its value in prognosis in an external validation cohort. Two PET datasets were retrospectively analysed: 297 patients from a local centre for training and 117 patients from an external centre for validation. A 3D U-Net architecture was trained on patches randomly sampled within the PET images. Segmentation performance was evaluated by six metrics, including the Dice similarity coefficient (DSC), Jaccard similarity coefficient (JSC), sensitivity (Se), positive predictive value (PPV), Hausdorff distance 95 (HD 95), and average symmetric surface distance (ASSD). Finally, the prognostic value of predictive total metabolic tumour volume (pTMTV) was validated in real clinical applications. The mean DSC, JSC, Se, PPV, HD 95, and ASSD (with standard deviation) for the validation cohort were 0.78 ± 0.25, 0.69 ± 0.26, 0.81 ± 0.27, 0.82 ± 0.25, 24.58 ± 35.18, and 4.46 ± 8.92, respectively. The mean ground truth TMTV (gtTMTV) and pTMTV were 276.6 ± 393.5 cm and 301.9 ± 510.5 cm in the validation cohort, respectively. Perfect homogeneity in the Bland-Altman analysis and a strong positive correlation in the linear regression analysis (R linear = 0.874, p < 0.001) were demonstrated between gtTMTV and pTMTV. pTMTV (≥ 201.2 cm) (PFS: HR = 3.097, p = 0.001; OS: HR = 6.601, p < 0.001) was shown to be an independent factor of PFS and OS. The FCN model with a U-Net architecture can accurately segment lymphoma lesions and allow fully automatic assessment of TMTV on PET scans for DLBCL patients. Furthermore, pTMTV is an independent prognostic factor of survival in DLBCL patients. The segmentation model based on a U-Net architecture shows high performance in the segmentation of DLBCL patients on FDG-PET images. The proposed method can provide quantitative information as a predictive TMTV for predicting the prognosis of DLBCL patients.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00330-022-08573-1Additional details
Identifiers
Publishing Information
- Journal Title
- European Radiology (Internet)
- Journal Volume
- 32
- Journal Issue
- 7
- Journal Page Range
- p. 4801-4812
- ISSN
- 1432-1084
- CODEN
- EURAE3
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 53085659
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- AUTOMATION; CORRELATIONS; DATA COMPILATION; FLUORINE 18; FLUORODEOXYGLUCOSE; GROUND TRUTH MEASUREMENTS; IMAGE PROCESSING; LYMPHOMAS; MACHINE LEARNING; METABOLISM; METRICS; NEURAL NETWORKS; PERFORMANCE; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; SENSITIVITY; THREE-DIMENSIONAL CALCULATIONS; TRAINING; VALIDATION
- Descriptors DEC
- ALGORITHMS; ANTIMETABOLITES; ARTIFICIAL INTELLIGENCE; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; COMPUTERIZED TOMOGRAPHY; DATA; DATA PROCESSING; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EDUCATION; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; IMMUNE SYSTEM DISEASES; INFORMATION; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LEARNING; LIGHT NUCLEI; MATERIALS; MATHEMATICAL LOGIC; MATHEMATICS; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; PROCESSING; RADIOACTIVE MATERIALS; RADIOISOTOPES; STATISTICS; TESTING; TOMOGRAPHY